BSE Live
Jan 01, 09:24Prev. Close
2770.25
Open Price
2798.95
Bid Price (Qty.)
2756.50 (17)
Offer Price (Qty.)
2759.90 (2)
NSE Live
Jan 01, 09:23Prev. Close
2768.90
Open Price
2787.60
Bid Price (Qty.)
2758.10 (1)
Offer Price (Qty.)
2760.00 (4)
| Key Financial Ratios of Ajanta Pharma (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 24.19 | 18.12 | 15.08 | 11.62 | 8.77 | |
| Diluted EPS (Rs.) | 24.19 | 18.12 | 15.08 | 11.62 | 8.77 | |
| Cash EPS (Rs.) | 40.94 | 29.27 | 20.99 | 17.36 | 14.02 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 149.12 | 128.98 | 113.76 | 102.25 | 92.95 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 149.12 | 128.98 | 113.76 | 102.25 | 92.95 | |
| Dividend / Share(Rs.) | 3.50 | 2.50 | 2.50 | 2.00 | 1.50 | |
| Revenue from Operations/Share (Rs.) | 323.54 | 270.71 | 241.53 | 202.35 | 174.64 | |
| PBDIT/Share (Rs.) | 61.46 | 51.81 | 39.59 | 31.12 | 24.75 | |
| PBIT/Share (Rs.) | 44.71 | 40.67 | 33.68 | 25.37 | 19.50 | |
| PBT/Share (Rs.) | 28.54 | 21.99 | 20.89 | 15.58 | 10.05 | |
| Net Profit/Share (Rs.) | 24.19 | 18.12 | 15.08 | 11.62 | 8.77 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 18.99 | 19.14 | 16.39 | 15.37 | 14.16 | |
| PBIT Margin (%) | 13.81 | 15.02 | 13.94 | 12.53 | 11.16 | |
| PBT Margin (%) | 8.81 | 8.12 | 8.64 | 7.69 | 5.75 | |
| Net Profit Margin (%) | 7.47 | 6.69 | 6.24 | 5.74 | 5.02 | |
| Return on Networth / Equity (%) | 16.22 | 14.05 | 13.25 | 11.36 | 9.43 | |
| Return on Capital Employed (%) | 8.63 | 6.83 | 7.68 | 8.04 | 7.13 | |
| Return on Assets (%) | 6.12 | 4.65 | 5.02 | 5.03 | 4.65 | |
| Total Debt/Equity (X) | 1.16 | 1.58 | 1.23 | 0.90 | 0.75 | |
| Asset Turnover Ratio (%) | 81.93 | 69.49 | 80.43 | 87.69 | 92.70 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.73 | 1.67 | 1.70 | 1.74 | 1.88 | |
| Quick Ratio (X) | 0.96 | 0.99 | 0.96 | 1.06 | 1.06 | |
| Inventory Turnover Ratio (X) | 3.63 | 3.23 | 3.13 | 3.46 | 3.28 | |
| Dividend Payout Ratio (NP) (%) | 14.35 | 13.69 | 16.45 | 17.08 | 16.97 | |
| Dividend Payout Ratio (CP) (%) | 8.48 | 8.47 | 11.82 | 11.43 | 10.62 | |
| Earnings Retention Ratio (%) | 85.65 | 86.31 | 83.55 | 82.92 | 83.03 | |
| Cash Earnings Retention Ratio (%) | 91.52 | 91.53 | 88.18 | 88.57 | 89.38 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 412.75 | 293.48 | 254.58 | 187.17 | 167.65 | |
| EV/Net Operating Revenue (X) | 1.08 | 0.92 | 0.89 | 0.78 | 0.81 | |
| EV/EBITDA (X) | 5.69 | 4.80 | 5.45 | 5.10 | 5.74 | |
| MarketCap/Net Operating Revenue (X) | 0.56 | 0.19 | 0.33 | 0.36 | 0.42 | |
| Retention Ratios (%) | 85.64 | 86.30 | 83.54 | 82.91 | 83.02 | |
| Price/BV (X) | 1.22 | 0.40 | 0.70 | 0.70 | 0.80 | |
| Price/Net Operating Revenue | 0.56 | 0.19 | 0.33 | 0.36 | 0.42 | |
| Earnings Yield | 0.13 | 0.35 | 0.19 | 0.16 | 0.12 |
30.12.2025
30.12.2025
26.12.2025
24.12.2025
Ajanta Pharma shares rise 5% on Biocon weight-loss drug marketing pact
10.11.2025
Ajanta Pharma Standalone September 2025 Net Sales at Rs 1,220.24 crore, up 8.09% Y-o-Y
04.11.2025
Ajanta Pharma Consolidated September 2025 Net Sales at Rs 1,353.73 crore, up 14.08% Y-o-Y
29.07.2025
Ajanta Pharma Consolidated June 2025 Net Sales at Rs 1,302.65 crore, up 13.78% Y-o-Y
29.07.2025
Ajanta Pharma Standalone June 2025 Net Sales at Rs 1,208.56 crore, up 12.19% Y-o-Y
12.07.2023
Ajanta Pharma Q1 PAT seen up 9.1% YoY to Rs 190.5 cr: Nirmal Bang
13.07.2022
Ajanta Pharma Q1 PAT may dip 12.7% YoY to Rs 151.6 cr: ICICI Direct
11.01.2019
Ajanta Pharma Q3 PAT may dip 35.1% YoY to Rs. 95.8 cr: ICICI Direct
12.10.2018
Ajanta Pharma Q2 PAT may dip 16.5% YoY to Rs. 110.1 cr: ICICI Direct